Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Subik

Podiatrist, Foot & Ankle Surgery Lyndhurst, NJ Doctor of Podiatric Medicine

NPI 1003813551 CMS profile 144

160 Ridge Rd, Lyndhurst, NJ 07071

Open in the dashboard

General payments

$528,599

573 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Subik of Lyndhurst, NJ is reported in the CMS Open Payments database as having received $528,599 across 573 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $82,469 104
2024 General $28,714 60
2023 General $53,139 73
2022 General $84,446 94
2021 General $87,843 88
2020 General $99,774 70
2019 General $92,213 84

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Subik
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Michael Subik were reported at $82,469. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Michael Subik Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $92,213 $389 $118–$1,406 $163
2020 $99,774 $191 $62–$691 $114
2021 $87,843 $329 $104–$1,341 $132
2022 $84,446 $419 $125–$1,611 $149
2023 $53,139 $377 $128–$1,164 $160
2024 $28,714 $394 $134–$1,168 $164
2025 $82,469 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $398,264 323 payments
  2. Orthofix Medical, Inc. $93,702 143 payments
  3. Davol Inc. $20,877 20 payments
  4. Trice Medical, Inc. $13,269 10 payments
  5. Smith+Nephew, Inc. $396 35 payments
  6. Integra LifeSciences Corporation $333 10 payments
  7. Misonix Inc $326 3 payments
  8. Kerecis Limited $166 2 payments
  9. Bone Support Inc. $156 2 payments
  10. MedShape, Inc. $148 1 payment
  11. Other $963 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $473,832 161 payments
  2. Travel and Lodging $37,598 144 payments
  3. Food and Beverage $13,609 263 payments
  4. Honoraria $3,480 3 payments
  5. Gift $77 1 payment
  6. Education $3 1 payment
Products named General payments · program years 2019–2025
  1. HOFFMANN Trauma & Extremeties $91,504 64 payments
  2. SALVATION $60,451 27 payments
  3. TrueLok $54,284 133 payments
  4. VARIAX Trauma & Extremeties $50,748 24 payments
  5. STAR $33,725 20 payments
  6. PROSTEP $27,886 22 payments
  7. PROPHECY $26,727 9 payments
  8. HOFFMANN Trauma & Extremeties $21,824 18 payments
  9. ANCHORAGE $20,069 11 payments
  10. VARIAX Trauma & Extremeties $19,776 10 payments
  11. Other $453,826 425 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 118 billing codes

Paid by Medicare

$89,587

Medicare's payments for the services billed

Medicare patients

194

Average age 78

Services billed

1,109

115 women, 79 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Alzheimer's or dementia 46%
Diabetes 43%
Depression 42%
Ischemic heart disease 38%
Heart failure 30%
Chronic kidney disease 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

573 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record